학술논문
Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
Document Type
Article
Author
Folegatti, Pedro M; Bittaye, Mustapha; Flaxman, Amy; Lopez, Fernando Ramos; Bellamy, Duncan; Kupke, Alexandra; Mair, Catherine; Makinson, Rebecca; Sheridan, Jonathan; Rohde, Cornelius; Halwe, Sandro; Jeong, Yuji; Park, Young-Shin; Kim, Jae-Ouk; Song, Manki; Boyd, Amy; Tran, Nguyen; Silman, Daniel; Poulton, Ian; Datoo, Mehreen; Marshall, Julia; Themistocleous, Yrene; Lawrie, Alison; Roberts, Rachel; Berrie, Eleanor; Becker, Stephan; Lambe, Teresa; Hill, Adrian; Ewer, Katie; Gilbert, Sarah
Source
In The Lancet Infectious Diseases July 2020 20(7):816-826
Subject
Language
ISSN
1473-3099